Transition is a biopharmaceutical company that develops novel therapeutics for central nervous system and metabolic disease indications... Read more
Transition is a biopharmaceutical company that develops novel therapeutics for central nervous system and metabolic disease indications... Read more
CEO
Add
News
Dec 05, 2019
BioPortfolio
Transition Therapeutics: Transition Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14122018 Prices from USD $220
Dec 18, 2018
BioPortfolio
Transition Therapeutics: Transition Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14122018 Prices from USD $250
Nov 01, 2018
BioPortfolio
Transition Therapeutics: Transition Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24092018 Prices from USD $250
Jun 01, 2017
BioPortfolio
Transition Therapeutics: Transition Therapeutics Inc TTH Pharmaceuticals Healthcare Deals and Alliances Profile Updated 17052017 Prices from USD $250
Mar 18, 2017
BioPortfolio
Transition Therapeutics: Transition Therapeutics Inc TTH Pharmaceuticals Healthcare Deals and Alliances Profile Updated 24022017 Prices from USD $250
Nov 29, 2016
PR-Inside
Press Release: Transition Therapeutics : New Study: Transition Therapeutics Inc. (TTH) - Financial and Strategic SWOT Analysis Review
Nov 28, 2016
BioPortfolio
Transition Therapeutics: Transition Therapeutics Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350
Nov 21, 2016
BioPortfolio
Transition Therapeutics: Transition Therapeutics Inc. TTH Financial and Strategic SWOT Analysis Review Prices from USD $300
Aug 30, 2016
The Business Journals
Transition Therapeutics: Phillip Frost's Opko Health completes $60M acquisition of biopharmaceutical firm
Aug 26, 2016
BioPortfolio
Transition Therapeutics: Transition Therapeutics Shareholders Approve Acquisition by OPKO Health
Transition Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10